Analytical Data
-
基因名
PDLIM4
- Application
-
别名
Enigma homolog; LIM domain protein; LIM domain protein RIL; LIM protein RIL; PDLI4_HUMAN; PDLIM 4; PDLIM4; PDZ and LIM domain 4; PDZ and LIM domain protein 4; Reversion induced LIM protein; Reversion-induced LIM protein
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P50479
-
表达区间
1-330 aa
-
氨基酸序列
MPHSVTLRGP SPWGFRLVGG RDFSAPLTIS RVHAGSKAAL AALCPGDLIQ AINGESTELM THLEAQNRIK GCHDHLTLSV SRPEGRSWPS APDDSKAQAH RIHIDPEIQD GSPTTSRRPS GTGTGPEDGR PSLGSPYGQP PRFPVPHNGS SEATLPAQMS TLHVSPPPSA DPARGLPRSR DCRVDLGSEV YRMLREPAEP VAAEPKQSGS FRYLQGMLEA GEGGDWPGPG GPRNLKPTAS KLGAPLSGLQ GLPECTRCGH GIVGTIVKAR DKLYHPECFM CSDCGLNLKQ RGYFFLDERL YCESHAKARV KPPEGYDVVA VYPNAKVELV
-
分子量
35.3 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
PDLIM4 (PDZ and LIM domain protein 4) is a member of the PDZ-LIM protein family, which has been implicated in various cellular processes, including cytoskeletal organization, signal transduction, and gene expression regulation. Recent studies have highlighted the potential role of PDLIM4 in cancer, particularly in regulating cell proliferation, apoptosis, and differentiation. Its expression is often altered in several cancer types, suggesting that PDLIM4 may function as a tumor suppressor or an oncogene depending on the context. Given its diverse interactions with other proteins, including those involved in signaling pathways and cell adhesion, the functional characterization of PDLIM4 through recombinant protein studies is essential. This research could elucidate the molecular mechanisms by which PDLIM4 influences cellular functions and contributes to tumorigenesis. By examining its structure, binding partners, and downstream effects, scientists aim to uncover the therapeutic potential of targeting PDLIM4 in cancer treatment. Understanding the biology of PDLIM4 could offer new insights into its role in health and disease, opening avenues for innovative therapeutic strategies.
